Medical Expertise at Medical Aesthetics & Lasers
Medical Aesthetics & Lasers is led by Ayaz Khan, MD , an experienced physician who has practiced aesthetic medicine, pain management, and addiction medicine in the United States since 2004. Dr. Khan has completed advanced medical training in anesthesiology and surgery and has additional training and certifications in aesthetic medicine. His multidisciplinary medical background informs a patient-centered approach to aesthetic and wellness treatments.
What makes one laser the best laser for hyperpigmentation for one patient, but a poor choice for another? The answer usually isn't the device name. It depends on whether the pigment is superficial or dermal, what caused it, your Fitzpatrick skin type, your tolerance for downtime, and how likely the condition is to recur.
A sharply defined sun spot, melasma, and post-inflammatory hyperpigmentation don't behave alike under laser energy. Melasma and PIH deserve particular caution because inflammation from an overly aggressive treatment can create more discoloration. Professional assessment, conservative settings, test spots when appropriate, and consistent photoprotection are central to safe planning.
The options below include combination regenerative care, topical support, Nd:YAG, fractional CO₂ and erbium, picosecond, alexandrite, and KTP lasers. The right plan may involve one of them, several in sequence, or no laser at all until the skin is calmer and the diagnosis is clear.
Table of Contents
- 1. Combination Laser and PRP or PRF Regenerative Protocol
- 2. Combination Laser and Topical Protocol Approach
- 3. Nd:YAG Laser at 1064 nm
- 4. Fractional Laser Technology with CO₂ and Erbium
- 5. Picosecond Lasers at 755 to 1064 nm
- 6. Alexandrite Laser at 755 nm
- 7. KTP Laser at 532 nm
- Top 7 Lasers & Protocols for Hyperpigmentation
- Choose the Treatment Plan, Not Just the Laser
1. Combination Laser and PRP or PRF Regenerative Protocol
Laser energy can disrupt unwanted pigment, while PRP or PRF may support the surrounding skin's recovery and overall quality. This is particularly useful when a patient also has dullness, early textural change, acne scarring, or a preference for a broader rejuvenation plan rather than isolated spot removal.
PRP, or platelet-rich plasma, is prepared from the patient's own blood. PRF, platelet-rich fibrin, uses a related autologous approach and forms a fibrin matrix that can remain in contact with tissue longer. Neither should be presented as a guaranteed antidote to laser downtime or as a substitute for careful laser selection. The regenerative component complements the procedure, but it doesn't eliminate the risk of inflammation or recurrent pigment.
A practical sequence may involve drawing blood before the laser treatment, then applying the prepared PRP or PRF immediately afterward if the protocol is appropriate. Some clinicians may use microneedling as a delivery method after laser treatment, but combining procedures requires careful judgment about barrier status, energy levels, and the patient's history of PIH.
Practical rule: Treat the pigment and the skin's tolerance as separate clinical problems. A regenerative add-on may improve the overall plan, but conservative laser parameters still matter most for preventing avoidable inflammation.
Patients considering this approach can learn more about PRF platelet-rich fibrin therapy. Treatment spacing, follow-up, topical maintenance, and sun protection should be individualized. A patient with melasma may need a different strategy from someone with isolated solar lentigines or post-acne marks.
2. Combination Laser and Topical Protocol Approach
Laser treatment addresses pigment that already exists. Topical care helps manage the biological signals that can create or sustain new discoloration. That makes combination treatment especially relevant for melasma and recurrent PIH, where removing visible pigment without controlling triggers often produces disappointing longevity.
A customized protocol might pair a carefully selected Nd:YAG or picosecond treatment with topical agents such as hydroquinone, niacinamide, vitamin C, tranexamic acid, or kojic acid. The choice depends on diagnosis, sensitivity, current inflammation, prior reactions, and whether the skin barrier can tolerate active ingredients. Hydroquinone, for example, shouldn't be treated as a universal solution or used indefinitely without medical supervision.
Topicals may begin before the first laser session when the clinician believes the skin can tolerate them. They may then be paused, modified, or reintroduced around treatment according to the device, treatment intensity, and recovery pattern.
- For sensitive skin: A clinician may favor gentler brightening and barrier-supportive options, such as niacinamide or vitamin C.
- For recurrence-prone pigment: Long-term maintenance may be more important than pursuing a stronger single laser session.
- For post-treatment care: Written instructions help patients avoid combining irritating products too soon after treatment.
Daily broad-spectrum sunscreen and physical protection remain important, but sunscreen alone shouldn't be presented as a complete strategy for laser-induced PIH. A 2026 systematic review and network meta-analysis found that several interventions, including intradermal and oral tranexamic acid, topical corticosteroids, topical vasoconstrictors, and epidermal cooling, reduced laser-induced PIH more than sunscreen alone, while sunscreen monotherapy was ineffective versus placebo. The findings are summarized in this review of interventions for laser-induced PIH.
A consultation can also determine whether a chemical peel belongs in the broader plan. Medical Aesthetics And Lasers provides hyperpigmentation-focused chemical peel education, but peel selection should follow diagnosis and skin tolerance rather than a desire to stack procedures quickly.
3. Nd:YAG Laser at 1064 nm
The 1064 nm Nd:YAG laser is a foundational option when pigment sits deeper or the patient has a higher risk of post-inflammatory hyperpigmentation. Melanin absorbs light most strongly in approximately the 600 to 1100 nm range, which explains why pigment-targeting devices include wavelengths such as 532 nm, 694 nm, 755 nm, and 1064 nm, as described in this review of laser wavelength principles.
The longer 1064 nm wavelength penetrates more and generally spares the epidermis more than shorter wavelengths. For that reason, low-fluence 1064 nm treatment is often favored in melasma management, particularly when the clinician is trying to limit epidermal injury. It can also be considered for selected sun damage and other pigment concerns across a range of skin tones.
A patient with Fitzpatrick IV or V skin and diffuse melasma may be a better candidate for a cautious longer-wavelength plan than for a strongly absorbed superficial laser. That doesn't make Nd:YAG risk-free. Melasma can recur, and overly aggressive energy can still provoke inflammation and worsening.
A careful plan commonly includes:
- Conservative starting settings: Lower fluence can help the clinician observe how the skin responds before considering adjustments.
- Adequate reassessment: Sessions should allow time to evaluate fading, irritation, and any darkening rather than escalating automatically.
- Photoprotection: SPF 50+ use, hats, shade, and avoidance of avoidable UV exposure support the treatment plan.
- Combination care: Topical brighteners or regenerative treatments may be considered when they address a separate clinical need.
For perspective, a 2023 network meta-analysis of melasma treatments ranked Q-switched Nd:YAG combined with topical medication highest for efficacy, with a SUCRA value of 85.9%. The same analysis ranked oral tranexamic acid at 80.1% and fractional carbon dioxide laser plus topical medication at 70.5%, supporting combination care over assuming laser monotherapy is always the strongest approach. The evidence appears in this melasma treatment network meta-analysis.

4. Fractional Laser Technology with CO₂ and Erbium
Fractional lasers create microscopic treatment zones rather than treating every millimeter of skin continuously. That design can address pigment, texture, acne scarring, and collagen remodeling in one treatment concept, but the trade-off is increased inflammation compared with gentler non-ablative approaches.
Fractional CO₂ operates at approximately 10,600 nm and produces deeper ablative remodeling. Fractional erbium operates at approximately 2,940 nm and generally provides more superficial resurfacing. The best choice depends on whether pigment is the only concern or whether the patient also wants meaningful correction of texture, scarring, or laxity.
A patient with sun-related discoloration and mild acne scarring may benefit from a resurfacing strategy that targets both problems. Another patient with melasma and a history of PIH may be a poor candidate for aggressive fractional treatment, especially if the diagnosis hasn't been confirmed or the skin is already irritated.
Where fractional treatment fits
Fractional erbium may appeal to someone seeking more superficial resurfacing and a potentially easier recovery. Fractional CO₂ may be considered when deeper remodeling is clinically justified, but it carries a greater need for careful preparation, aftercare, and downtime planning.
The treatment season, recent procedures, and skin condition all matter. Strong UV exposure can complicate recovery, so clinicians may prefer periods when patients can reliably use sunscreen, hats, and shade. Invasive treatments also shouldn't be crowded together without a clear reason. A patient considering PDO threads, for example, may need the skin to heal before another procedure is scheduled.
A 2013 clinical study of fractional erbium glass laser for melasma reported a 62.9% reduction in MASI score after 12 weeks in the laser group, illustrating that measurable change can occur over roughly three months when treatment is appropriately selected. The result comes from the same melasma treatment evidence review, but it shouldn't be interpreted as a promise for every patient or every fractional platform.
Patients seeking a broader tone and texture plan can review hyperpigmentation treatment options at Medical Aesthetics And Lasers. The clinical priority remains diagnosis first, followed by a treatment intensity the skin can tolerate.

5. Picosecond Lasers at 755 to 1064 nm
Picosecond lasers deliver energy in extremely short pulses designed to fragment pigment through a photoacoustic effect, with less time for heat to spread into adjacent tissue. They may be useful for selected epidermal, dermal, or exogenous pigment, depending on wavelength and settings.
Common platforms may offer 755 nm alexandrite, 532 nm frequency-doubled, and 1064 nm Nd:YAG wavelengths. The clinician should select the wavelength according to pigment depth and diagnosis, not simply choose the shortest pulse because it sounds more advanced. A 755 nm wavelength may suit more superficial targets, while 1064 nm can reach deeper pigment with a longer-wavelength approach.
Picosecond treatment can be attractive for dense solar lentigines or selected pigment that has plateaued with another approach. It may also be incorporated into a broader skin-quality plan, although adding radio-frequency microneedling or other procedures requires attention to cumulative inflammation.
Faster pulses don't remove the need for slower clinical judgment. A picosecond device can still worsen pigment when the diagnosis, fluence, spot size, or treatment cadence is wrong.
The comparative evidence is nuanced. A 2026 systematic review covering 20 randomized controlled trials plus one retrospective comparative study, with 971 patients, found comparable clearance between picosecond and nanosecond lasers for endogenous hyperpigmentation. Picosecond devices trended better for exogenous hyperpigmentation, with a relative risk of 1.39, a 95% confidence interval of 0.99 to 1.94, and P = 0.05, as reported in this systematic review of picosecond and nanosecond lasers.
That evidence supports lesion-specific selection rather than marketing-led device choice. Patients still need realistic counseling about gradual clearing, sun protection, and the possibility that combination topical treatment is more appropriate than increasing laser intensity.

6. Alexandrite Laser at 755 nm
The 755 nm alexandrite wavelength occupies a middle position between shorter superficial wavelengths and the deeper-penetrating 1064 nm Nd:YAG. Q-switched alexandrite can target melanin in epidermal to mid-dermal pigment, but the same absorption that makes it useful can increase risk in patients with more melanin-rich skin.
A clinician may consider it for selected solar lentigines or other discrete lesions when the pigment is suitable and the patient's skin has been assessed carefully. It can also appear on multifunction platforms used for hair removal, but that doesn't mean the same settings or treatment logic apply to pigment. Hair follicles and pigmented lesions are different targets.
For a Fitzpatrick IV patient with a specific, well-defined lesion, a test spot may be more informative than committing immediately to full-face treatment. For diffuse melasma, the decision is more complicated because the condition is biologically active and recurrence-prone. A mid-wavelength device isn't automatically safer just because it isn't the shortest or longest option.
Managing the trade-off
Alexandrite treatment may offer a useful compromise for selected pigment depth, but it requires a conservative approach:
- Test the skin first: A test spot can reveal unexpected darkening, lightening, or prolonged inflammation.
- Start cautiously: Lower initial fluence is particularly important in darker skin types and in patients with a history of PIH.
- Allow clearance time: Treatments shouldn't be repeated just because the pigment hasn't disappeared immediately.
- Control triggers: Daily SPF 50+, shade, and appropriate topical maintenance can help limit new pigment after treatment.
- Review the diagnosis: Melasma, PIH, lentigines, and dermal pigment don't share the same risk profile.
The best use of alexandrite is therefore selective. A provider who understands skin type, pigment depth, and prior treatment response can decide whether its advantages outweigh the risk of inflammation for a particular patient.
7. KTP Laser at 532 nm
The KTP laser uses a 532 nm green wavelength that is strongly absorbed by superficial melanin. That makes it a logical option for selected epidermal lesions, including some solar lentigines and sharply defined age spots, particularly in lighter skin types.
Its shorter wavelength is also the central limitation. The more strongly pigment absorbs the energy, the more carefully the clinician must manage fluence, spot size, cooling, and test treatment. In Fitzpatrick IV, V, and VI skin, or in anyone with a personal history of PIH, a 532 nm approach may carry more concern than a longer-wavelength strategy.
A fair-skinned patient with several discrete sun spots on the face, chest, or hands may value the speed and focused nature of KTP treatment. The same treatment would require a more cautious discussion for diffuse melasma, active acne-related inflammation, or generalized discoloration. KTP isn't a universal answer for uneven tone.
What patients should expect
The treated spots may temporarily darken before they fade. That visible change can be unsettling if the patient wasn't warned, so aftercare counseling matters as much as the device choice. Strict sun avoidance during the early healing period, broad-spectrum SPF 50+, and follow-up help the clinician assess whether the skin is clearing normally.
KTP may be considered for superficial pigment, but it isn't usually the first conversation for higher-risk skin types. Expert guidance from the European Society of Laser in Dermatology cautions that melasma, café au lait macules, and PIH aren't uniformly responsive and carry higher risk, even though lasers and IPL can be effective for conditions such as lentigines and dermal hypermelanocytosis. The guidance is available in this European laser dermatology position paper.
The most useful comparison is not KTP versus every other device. It's superficial, well-defined pigment versus a diffuse or inflammation-sensitive condition. That distinction determines whether fast superficial targeting is sensible or whether a more conservative plan is needed.
Top 7 Lasers & Protocols for Hyperpigmentation
| Item | Implementation complexity | Resource requirements | Expected outcomes | Ideal use cases | Key advantages |
|---|---|---|---|---|---|
| Combination Laser + PRP/PRF Regenerative Protocol | High, coordinates laser + autologous blood processing and timing | Laser device, PRP/PRF centrifuge & kits, trained staff, extra patient time | Faster epithelial healing, enhanced collagen, improved pigmentation & texture, reduced downtime/PIH | Patients seeking premium regenerative results, pigment + texture concerns, those wanting reduced recovery | Accelerated healing, lower PIH risk, superior skin-quality improvement |
| Combination Laser + Topical Protocol Approach | Moderate, requires regimen planning and patient adherence | Laser device, prescription/topical agents, patient education and follow-up | Better pigment clearance, fewer sessions, lower recurrence with maintenance topicals | Resistant or recurrent melasma, prevention-focused plans, long-term maintenance | Reduced recurrence, evidence-based synergy, sustained results with maintenance |
| Nd:YAG Laser (1064 nm) | Moderate, requires wavelength/pulse customization for skin tone | Nd:YAG laser, trained operator, multiple sessions (4–8) | Deep penetration pigment reduction, collagen stimulation, visible results in weeks | Melasma and age spots in darker skin types (Fitz IV–VI), mixed-depth pigment | Safer for darker skin, treats superficial and deep pigment, versatile settings |
| Fractional Laser Technology (CO₂ & Erbium) | High, ablative/thermal management and PIH mitigation necessary | CO₂/Erbium fractional device, downtime support, skilled operator | Significant resurfacing, strong collagen remodeling, improved texture and pigment | Patients with pigment plus scarring/texture/laxity who accept downtime | Dramatic resurfacing, addresses multiple concerns in few sessions |
| Picosecond Lasers (755–1064 nm) | Moderate–High, wavelength selection and operator skill important | High-cost picosecond device, multiple wavelength options, trained staff | Rapid photoacoustic pigment fragmentation, fewer sessions, minimal thermal damage/downtime | Resistant melasma, dense lentigines, patients wanting fast recovery | Faster clearance, reduced thermal injury, fewer treatments needed |
| Alexandrite Laser (755 nm) | Moderate, fluence selection and test spots recommended | Alexandrite/Q-switched platform (often multi-function), trained operator | Effective for epidermal to mid-dermal pigment, gradual improvement over sessions | Mid-depth pigmentation, Fitzpatrick III–IV, practices combining hair removal & pigment work | Versatile mid-wavelength, multi-use platforms, established clinical track record |
| KTP Laser (532 nm) | Low–Moderate, simple delivery but high skin-type caution | KTP (532 nm) device, brief treatment sessions, lower per-session cost | Rapid clearance of superficial epidermal spots, minimal downtime but PIH risk in darker skin | Superficial lentigines/age spots in fair skin (Fitz I–III), quick maintenance treatments | Fast, cost-effective for superficial pigment, minimal social downtime |
Choose the Treatment Plan, Not Just the Laser
The best laser for hyperpigmentation depends first on the diagnosis and pigment depth. Superficial lentigines may respond to a more directly absorbed wavelength, while dermal pigment and higher-risk skin types may call for a longer-wavelength, lower-inflammation strategy. Melasma and PIH require especially careful planning because the treatment can trigger the same inflammatory process that contributed to the discoloration.
Fitzpatrick skin type matters, but it isn't the only variable. A patient with lighter skin can still develop PIH, and a patient with darker skin may tolerate a carefully selected treatment well. Prior reactions, current acne or dermatitis, recent tanning, medication use, hormonal factors, and the presence of active melasma all change the risk calculation.
Treatment goals also influence the choice. If the concern is a few isolated spots, a focused pigment laser may be reasonable. If the patient also wants improvement in acne scarring, laxity, dullness, or uneven texture, fractional resurfacing, microneedling, PRP, or PRF may have a role. Those additions should be sequenced deliberately rather than layered together just because more procedures sound more thorough.
The safest plan is the one that balances pigment clearance with inflammation control, not the one that uses the most powerful device.
Combination care often makes more sense than laser monotherapy. In melasma, the available evidence supports pairing selected laser treatment with topical medication rather than assuming a laser alone will prevent recurrence. In skin of color, a 2024 systematic review found complete resolution with lasers in a subgroup representing 26% of patients, while PIH worsening was also reported in some cases, reinforcing that response is variable and complications are possible. The findings are discussed in this systematic review of hyperpigmentation treatments in skin of color.
A personalized evaluation at Medical Aesthetics And Lasers can help determine whether laser, topical care, chemical peels, PRP, PRF, or a staged combination is appropriate. Expect realistic counseling, possible test spots, follow-up visits, and gradual improvement rather than instant clearance. Consistent SPF 50+ protection, physical barriers, and trigger control remain essential because recurrence can occur even after a successful treatment course.
Medical Aesthetics And Lasers offers personalized hyperpigmentation management alongside laser services, topical planning, and relevant PRP and PRF options for skin quality and recovery support. Visit Medical Aesthetics And Lasers in Williamsport, Pennsylvania, to schedule an individualized consultation and discuss the safest plan for your skin type, pigment pattern, and treatment goals.